This study systematically evaluated the safety profile of tumor necrosis factor-alpha (TNF-α) inhibitors in pediatric patients using data from the U.S. Food and Drug Administration (FDA) Adverse Event
Background Shock is a life-threatening clinical condition characterized by high morbidity and mortality. Drug-induced shock represents a complex subset of adverse drug reactions that has not been syst
